CVS Caremark Corp
featured
The "Fast Money" traders share their final trades of the day.
» Read More
More
-
Potential pitfalls in the credit markets and pressure from steadily rising oil prices could create new turbulence in a stock market that analysts say would otherwise benefit from stronger-than-expected corporate earnings.
-
In a sign of the growing influence that restaurants have on how and where consumers spend their money, a major retail trade group has included for the first time six restaurant companies on its list of the top 100 retailers, released on Friday.
-
Rite Aid, the third-largest U.S. drugstore chain, posted a higher quarterly profit Thursday as an income tax benefit and a gain on asset sales offset acquisition costs.
-
There are ways to play the stock market when interest rates are rising, analysts say, but investors should proceed with caution. "The market doesn't normally do well with rising interest rates, so a more defensive posture is in order," Bruce Bittles, chief investment strategist at Robert W. Baird, told CNBC.com."
-
Medco Health Solutions, the top U.S. prescription benefit manager, has wrested a prized federal contract to handle mail order prescriptions for more than 4 million people back from a top rival.
-
Is it time to take profits or cut losses? This is the segment where Cramer lets you know.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
-
We have an earnings video news report by CNBC/Wall Street Journal Editor Bob O'Brien. Bob looked at three companies--Disney, CVS Caremark and Molson-Coors. Disney reports after the bell today and CVS has already reported. Molson has yet to.
-
Drugstore chain CVS/Caremark said Tuesday first-quarter earnings rose 24.1% on strong sales at its pharmacy and front-end retail business.
-
Household products, oil drillers, healthcare, materials, telecom, international brokers, agriculture, aerospace, biotech – these are the sectors Cramer thinks will rally the hardest. He suggests you buy now.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
-
Hi all. Here's a report that ran on CNBC-TV today that might be of interest. It's money manager Mike Koskuba of Victory Capital Management on stocks he thinks have a great upside coming to them--and stock holders. Now, these are not necessarily for you to add to your contest picks (or your personal portfolio) and you might to get tremendous gains, but they are some stocks to think about.
-
Pharmacy benefit manager Express Scripts reported a 28% rise in quarterly profit Monday that beat Wall Street expectations, helped by increased use of generic drugs, and raised its profit forecast.
-
Texas' Attorney General said he filed a court action against CVS/Caremark, after finding customer records including personal information in a trash dumpster behind one of the chain's Texas stores.
-
Mattel, CVS, Intuitive Surgical and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
-
Saks, Acadia Pharma, Geron, Harley Davidson, Walgreen and more...Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
-
The guys go behind the headlines and give you their take on... Dell's delay... CVS vs. Walgreen... and more. Find out where they see fast money.
-
Caremark Rx shareholders on Friday approved a roughly $24 billion takeover offer from drug-store chain CVS bringing to an end a months-long takeover fight with Express Scripts for the rival pharmacy benefits manager.
-
Okay--here's our current celebrity standings as of the market close on Thursday, 3/15. Overall their approach is still a lot more conservative than the majority of our non-celeb leaders - more stable companies and purchases spread across multiple stocks, and it might end up being a race to see who can lose the least. But that's probably to be expected....
-
Shareholders of CVS, the No. 2 U.S. drugstore chain, approved the company's $23.9 billion plan to buy pharmacy benefits manager Caremark Rx.
-
Influential proxy advisory firm Institutional Shareholder Services said on Tuesday it recommends that Caremark Rx shareholders support a takeover proposal from drugstore chain CVS, reversing its previous stance.
-
In an exclusive interview with CNBC's David Faber, Express Scripts' CEO George Paz said his nearly $27 billion bid for Caremark Rx is his "best and only" offer unless the rival pharmacy-benefits manager opens its financial records for review.